Lipoprotein Lipase Antikörper (C-Term)
Kurzübersicht für Lipoprotein Lipase Antikörper (C-Term) (ABIN926449)
Target
Alle Lipoprotein Lipase (LPL) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Aufreinigung
- Purified
-
Immunogen
- LPL antibody was raised in rabbit using the C terminal of LPL as the immunogen
-
-
-
-
Applikationshinweise
- Optimal conditions should be determined by the investigator.
-
Kommentare
-
LPL Blocking Peptide, (ABIN940389), is also available for use as a blocking control in assays to test for specificity of this LPL antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- Lipoprotein Lipase (LPL)
-
Andere Bezeichnung
- LPL
-
Hintergrund
- LPL encodes lipoprotein lipase, which is expressed in heart, muscle, and adipose tissue. LPL functions as a homodimer, and has the dual functions of triglyceride hydrolase and ligand/bridging factor for receptor-mediated lipoprotein uptake. Severe mutations that cause LPL deficiency result in type I hyperlipoproteinemia, while less extreme mutations in LPL are linked to many disorders of lipoprotein metabolism. Synonyms: Polyclonal LPL antibody, Anti-LPL antibody, lipoprotein lipase antibody, HDLCQ11 antibody, LIPD antibody.
-
Pathways
- Lipid Metabolism
Target
-